GCM
CL icon

Genus Capital Management’s Colgate-Palmolive CL Stock Holding History

Genus Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,755
Closed -$3.43M – 226
2024
Q4 		$3.43M Sell
37,755
-29,033
-43% -$2.77M 0.47% 75
2024
Q3 		$6.93M Buy
66,788
+9,975
+18% +$1.02M 0.91% 35
2024
Q2 		$5.51M Buy
+56,813
New +$5.24M 0.73% 50
2024
Q1 		– Sell
-37,830
Closed -$3.02M – 240
2023
Q4 		$3.02M Buy
+37,830
New +$2.84M 0.44% 77

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Genus Capital Management's CL Position: Q2 2026 in Review

Genus Capital Management increased its Colgate-Palmolive (CL) stake by 64% in Q2 2026, buying an estimated $3.31M and bringing the position to 97,163 shares worth $8.91M. The position accounts for 0.88% of the portfolio, ranked #36.

Genus Capital Management first reported a position in CL in Q2 2023 and has held it in 5 quarters since. 867 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Genus Capital Management held 97,163 shares of Colgate-Palmolive worth $8.91M as of Q2 2026.
  • Genus Capital Management bought 37,838 Colgate-Palmolive shares in Q2 2026, an estimated $3.31M.
  • Colgate-Palmolive made up 0.88% of Genus Capital Management's portfolio in Q2 2026, its #36 holding.
  • Genus Capital Management first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 5 quarters since.
  • 867 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.